BDBM50225019 2-(4-((1-benzylpiperidin-4-yl)methoxy)phenyl)-1H-benzo[d]imidazole-5-carboxamide::CHEMBL249959
SMILES: NC(=O)c1ccc2nc([nH]c2c1)-c1ccc(OCC2CCN(Cc3ccccc3)CC2)cc1
InChI Key: InChIKey=LTUJRTNXSJGLBT-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serine/threonine-protein kinase CHK2 (Homo sapiens (Human)) | BDBM50225019 (2-(4-((1-benzylpiperidin-4-yl)methoxy)phenyl)-1H-b...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem Patents Similars | PDB Article PubMed | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Inhibition of human recombinant Chk2 | Bioorg Med Chem Lett 17: 6467-71 (2007) Article DOI: 10.1016/j.bmcl.2007.09.098 BindingDB Entry DOI: 10.7270/Q2KP81XB | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) |